IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
0.249
+0.008 (3.49%)
At close: Dec 20, 2024, 4:00 PM
0.250
+0.001 (0.48%)
After-hours: Dec 20, 2024, 7:51 PM EST
IN8bio Market Cap
IN8bio has a market cap or net worth of $18.03 million as of December 20, 2024. Its market cap has decreased by -42.90% in one year.
Market Cap
18.03M
Enterprise Value
19.50M
1-Year Change
-42.90%
Ranking
Category
Stock Price
$0.25
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $18.03M, a decrease of -90.38%. That is a compound annual growth rate of -49.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 18.03M | -69.78% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Senti Biosciences | 18.22M |
| Bullfrog AI | 18.21M |
| Flora Growth | 18.14M |
| Cyclo Therapeutics | 18.12M |
| NRx Pharmaceuticals | 18.09M |
| MIRA Pharmaceuticals | 17.55M |
| XTL Biopharmaceuticals | 17.54M |
| Carisma Therapeutics | 17.45M |